Electrogenic transport and K(+) ion channel expression by the human endolymphatic sac epithelium by 源��꽦�뿄 et al.
1Scientific RepoRts | 5:18110 | DOI: 10.1038/srep18110
www.nature.com/scientificreports
Electrogenic transport and K+ ion 
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The endolymphatic sac (ES) is a cystic organ that is a part of the inner ear and is connected to the 
cochlea and vestibule. The ES is thought to be involved in inner ear ion homeostasis and fluid volume 
regulation for the maintenance of hearing and balance function. Many ion channels, transporters, 
and exchangers have been identified in the ES luminal epithelium, mainly in animal studies, but there 
has been no functional study investigating ion transport using human ES tissue. We designed the first 
functional experiments on electrogenic transport in human ES and investigated the contribution of K+ 
channels in the electrogenic transport, which has been rarely identified, even in animal studies, using 
electrophysiological/pharmacological and molecular biological methods. As a result, we identified 
functional and molecular evidence for the essential participation of K+ channels in the electrogenic 
transport of human ES epithelium. The identified K+ channels involved in the electrogenic transport 
were KCNN2, KCNJ14, KCNK2, and KCNK6, and the K+ transports via those channels are thought to 
play an important role in the maintenance of the unique ionic milieu of the inner ear fluid.
The inner ear is composed of three luminal structures termed the cochlea, vestibule and endolymphatic sac (ES) 
(Fig. 1); the main roles of the inner ear are detecting sound and angular/linear acceleration stimulation, which occur 
in the cochlear and vestibular systems, respectively. The outer border of the membranous inner ear is lined with 
various types of epithelial cells, and the luminal space is filled with a fluid called endolymph, which has a unique 
ion composition (high [K+] and low [Na+] in the cochlea and vestibule and high [Na+] and low [K+] in the ES, 
Fig. 1)1–4. This unique ion composition is important for the maintenance of normal hearing and balance because it 
provides K+ into sensory hair cells of the cochlea and vestibule, which depolarizes the sensory epithelium during 
sound and acceleration stimuli. Among the three structures, the ES is a cystic organ that is situated on the posterior 
fossa dura and is connected to the cochlear and vestibular labyrinth through the ductus reuniens, the utricular 
duct, and the saccular duct (Fig. 1). The luminal surface of the ES is covered with a single layer of epithelium that 
is composed of two main cell types: mitochondria-rich cells (light cells) and ribosome-rich cells (dark cells)5,6. 
The mitochondria-rich cells contain various ion channels and transporters on their membranes and are thought 
to be mainly involved in the ion homeostasis of the luminal fluid of the inner ear, whereas the ribosome-rich cells 
contain many secretory granules and are thought to be involved in protein synthesis and secretion6–10. A discon-
nection between ES and the cochleo-vestibular compartment by ligating the endolymphatic duct increases the 
endolymphatic fluid volume (endolymphatic hydrops) in guinea pig11. Based on the suggested cellular functions 
and animal experimentation, one of the possible roles of ES has been thought to be the regulation of inner ear ion 
homeostasis and endolymph volume. However, the luminal fluid of the ES has different ion and protein composi-
tions (high Na+, low K+, and high protein concentration, Fig. 1) compared to the endolymph of the cochlear and 
vestibular compartment1–4, and the mechanism of the ES in the regulation of ion homeostasis and fluid volume 
of the whole inner ear remains unknown.
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It has been thought that various ion transport activities in ES play an important role in regulating ion homeosta-
sis of the inner ear; however, there have been no reports of a functional experiment for ion transport in human ES 
epithelium. Therefore, we attempted to investigate the electrogenic transport occurring in human endolymphatic 
sac epithelium, as it had not been reported elsewhere. Various ion channels, transporters, and exchangers have 
been reported in ES epithelium only by animal or cultured cell experiments: a highly Na+-permeable non-selective 
cation channel, Na+-Cl− co-transporter, Na+-K+-2Cl− co-transporter (NKCC), epithelial Na+ channel (ENaC), 
Na+-H+ exchanger (NHE), pendrin, and H+-ATPase on the apical side and Na+, K+-ATPase and K+ channels on 
the basolateral side12. The distribution of these ion channels, transporters, and exchangers according to specific 
epithelial cell types was not functionally identified because of difficulty in the identification of cell types during 
functional experiments. In particular, there are several limitations in the functional studies of ion transport in 
human ES epithelium. First, opportunities for obtaining human ES tissue are rare. However, as harvesting ES can 
deteriorate inner ear function, the tissue is best obtained from human subjects during inner ear function–destruc-
tive surgery, such as acoustic tumour removal. Second, cell types of human ES are more varied than are those of 
animals, and it is difficult to definitely divide them into the two cell types13. Therefore, it is very difficult to identify 
the specific cell types during functional studies.
In this study, we measured the net physiologic trans-epithelial current that is produced by various ion channels 
in the human ES epithelium harvested during acoustic tumour surgery instead of measuring the current that is 
produced by a single cell because the specific cell types could not be identified during the measurement, and the 
net trans-epithelial current is more indicative of whole-organ function. During the experiment, we found that 
K+ channels essentially participated in the electrogenic transport in human ES epithelium in almost all cases, a 
phenomenon that had not been directly identified in animal or human ES tissues. Therefore, we tried to inves-
tigate certain K+ channels and exchangers that contribute to electrogenic transport in human ES using not only 
electrophysiological and pharmacological methods but also molecular biological methods, such as RT-PCR and 
immunohistochemistry. The results of this study may contribute to the elucidation of the role of human ES in the 
regulation of inner ear ion homeostasis, which is essential for maintaining normal hearing and balance functions.
Results
Net trans-epithelial ion transport current. We measured the trans-epithelial current from the human ES 
epithelium of the tissue sample which had been excised into approximately 3 × 3 mm and then smoothly folded 
apical side-out using the scanning vibrating electrode technique (Fig. 2a). When the electrode was moved from 
the reference position (400 μ m from the tissue) close to the human ES epithelium, three types of current vectors 
were observed (Fig. 2b-c). The net-transepithelial current vector could be classified into three types: type 1 - cation 
secretion/anion absorption current vector [mean: 6.4 ± 0.1 μ A/cm2 (p < 0.001), n = 22]; type 2 - cation absorp-
tion/anion secretion current vector [mean: -10.0 ± 0.3 μ A/cm2 (p < 0.001) n = 20]; and type 3 - neutral current 
vector [no detectable current change compared to the current from the reference position; mean: 0.2 ± 0.2 μ A/cm2 
(p > 0.05), n = 15]. The current vectors were randomly changed according to the location of the measurement. 
This result implies that ion transport in the human ES epithelium was so heterogeneous that the net current vector 
could be different depending on the area of measurement.
Figure 1. Structures and chemical compositions of endolymph of the inner ear. The endolymphatic sac is 
connected to the cochlear and vestibular systems through the ductus reuniens (DR), the utricular duct (UD), 
and the saccular duct (SD) and has a different endolymphatic potential and ion and protein composition 
compared to those of the cochlear and vestibular systems. ESP, endolymphatic sac potential; ECP, endocochlear 
potential; UP, utricular potential.
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Figure 2. Different net current vectors that were detected during the measurement of the trans-epithelial 
current from the human endolymphatic sac (ES) epithelium. (a) A picture taken during trans-epithelial 
current measurement (× 100). ES was excised into ~ 3 × 3-mm-sized pieces (blue rectangle in the whole human 
ES sample in smaller rectangular figure. Scale bar = 5 mm) and smoothly folded before measurement. The 
trans-epithelial current was measured with a vibrating probe (VP) located at a distance of 5 ± 2 μ m from the 
ES epithelium. (b) Net current vector of cation secretion/anion absorption (type 1). (c) Net current vector of 
cation absorption/anion secretion (type 2). (d) Net neutral current vector (type 3). The averages of all of the 
experiments are shown; SE is drawn only at intervals for clarity.
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Trans-epithelial transport current. During the experiment using pharmacologic agents to block various 
ion channels, transporters, and exchangers, we found that the trans-epithelial current likely mediated by K+ ions 
was most consistently detected. When we applied Ba2+ (1 mM), a wide-spectrum non-specific K+ channel blocker, 
the cation-secretion current decreased in 9 of 10 cases (amount of mean current change: 18.9 ± 5.5 μ A/cm2, n = 10, 
p = 0.032, Fig. 3a,f): 4 cases with type 1 basal current vector, 2 cases with type 2 basal current vector, and 3 cases 
with type 3 basal current vector. No significant current change was detected even after Ba2+ application in one case 
with type 3 basal current vector. The amounts of current change after Ba2+ application were significantly larger than 
the amounts of basal current in all cases (Fig. 3f). The current change was insignificant with Ba2+ concentrations 
of 10−3 and 10−2 mM; however, the current was significantly changed at a Ba2+ concentration of 10−1 mM and 
changed more in terms of magnitude at a concentration of 1 mM (Fig. 3b). These findings were most similar to 
the characteristics of KCNJ13, KCNJ14, KCNK2, and KCNK614,15.
When the non-specific K+ channel blocker 4-aminopyridine (4-AP, 10 mM), which mostly blocks voltage-gated 
K+ channels, was applied, the cation secretion current significantly decreased in 4 of 5 cases (mean current change: 
24.6 ± 7.6 μ A/cm2, n = 5, p = 0.049, Fig. 3c,f): 1 case with type 1 basal current vector, and 3 cases with type 2 basal 
current vector. The amount of current changes after the application of 4-AP was also larger than the amount of 
basal current (Fig. 3f). The transepithelial current was not significantly changed after 4-AP application in 1 case 
with type 2 basal current vector. The simultaneous application of 4-AP and Ba2+ decreased the cation secretion 
current more than did the application of 4-AP only in 3 cases with type 3 basal current vectors (amount of mean 
current change after 4-AP application and 4-AP + Ba2+ application was 4.9 ± 0.2 μ A/cm2 and 11.0 ± 2.1 μ A/cm2, 
respectively, p = 0.037, Fig. 3d).
We tried to apply apamin (100 nM), a specific SK channel blocker, because an apamin-sensitive SK channel 
(KCNN2 channel) was later identified in liquid chromatography tandem mass spectrometry (LC-MS/MS; see 
section Ion channels, transporters, and exchangers in human ES as identified by LC-MS/MS). After the application 
of apamin, the cation-secretion current decreased in 2 cases with type 1 basal current vectors (current change: 3.9 
and 2.1 μ A/cm2 for each respective experiment, Fig. 3e) and the amount of current changes was not larger than 
the amount of basal current.
In summary, the amount of mean current changes was larger than the amount of mean basal current after the 
application of Ba2+ and 4-AP (Fig. 3f) and was not larger than the amount of mean basal current after the applica-
tion of apamin. The larger amount of current changes after the application of Ba2+ and 4-AP than the amount of 
basal current represents the presence of multiple ion transports with opposite current vectors (cation absorption/
anion secretion and cation secretion/anion absorption), and the K+ channel blockers inhibited apical secretion of 
K+ channels or influenced the apical cation secretion/anion absorption through multiple ion channels by inhibiting 
K+ channel activities in human ES epithelium.
Figure 3. Changes in the trans-epithelial current from human ES after the application of K+ channel 
blockers. (a) Changes of trans-epithelial current after Ba2+ (1 mM) application. (b) Dose-dependent changes 
of trans-epithelial current after various concentrations of Ba2+. (c) Inhibition of the K+ secretion current after 
4-AP (10 mM) application. (d) Larger effect of the simultaneous application of 4-AP (10 mM) and Ba2+ (1 mM) 
than that of 4-AP (10 mM) alone on the trans-epithelial current. (e) Representative figure for the changes of 
trans-epithelial current after apamin (100 nM) application. (f) Comparison of the mean basal current, changes 
in the current after the application of K+ channel blockers, and the absolute amount of current density change 
according to the K+ blockers that were used. The changes in the current density after the application of Ba2+ 
(1 mM) and 4-AP (10 mM) were greater than the amount of basal current. Values are means ± SE. All figures 
except for Figures b and e show the averages of all experiments; SE is drawn only at intervals for clarity in 
Figures a, c, and d. *p < 0.05.
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Ouabain (1 mM) and bumetanide (10 μ M) were used to identify the involvement of Na+, K+-ATPase, and Na+, 
K+, 2Cl−-cotransporter in the electrogenic transport in human ES epithelium. Ouabain decreased the apical cation 
absorption/anion secretion current by 18.0 μ A/cm2 (Fig. 4a) in one case with a type 2 basal current vector and by 
4.1 μ A/cm2 in one case with a type 3 basal current vector. In contrast, bumetanide decreased the cation secretion/
anion absorption current by 11.2 μ A/cm2 (Fig. 4b) in one case with a type 1 basal current vector and by 3.0 μ A/cm2  
in one case with a type 2 basal current vector.
These results indicate that multiple K+ channels, such as the Kir, Kv, K2P , and SK channels distributed in human 
ES epithelium and the trans-epithelial current was dependent on those functional K+ channels. Na+, K+ -ATPase 
and Na+-K+-2Cl− cotransporter likely supplied K+ into the ES epithelial cells, which could be a source for K+ ion 
transport through K+ channels.
Ion channels, transporters, and exchangers in human ES as identified by LC-MS/MS. LC-MS/MS 
was performed using human ES tissue to identify ion channels, transporters, and exchangers carrying the K+ 
ion. A total of 2762 proteins were identified from the human ES by LC-MS/MS. Among the proteins, 37 were ion 
channels, transporters, and exchangers (Table 1). These proteins consisted of Ca2+ channels, transient receptor 
potential (TRP) channels, K+ channels, Na+ channels, non-selective cation channels, Na+, K+-ATPase, and ion 
exchangers, and Cl− channel. The K+ channels that were identified in LC-MS/MS were 3 voltage-gated channels 
[KCNB1(gi|186798), KCNC4(gi|338077), and KCNH1(gi|27437001)] and 1 apamin-sensitive SK channel [KCNN2 
(gi|10334701)].
RT-PCR of K+ channels identified by LC-MS/MS and electrophysiological/pharmacological studies. 
RT-PCR was performed to verify the transcript expression of K+ channels as identified by LC-MS/MS (KCNB1, 
KCNC4, KCNH1, and KCNN2) and that are hypothesized to exist according to electrophysiological and pharma-
cological studies (KCNJ13, KCNJ14, KCNK2, and KCNK6) in the human ES. As a result, the transcript expression 
of KCNB1, KCNN2, KCNJ14, KCNK2, and KCNK6 were identified by RT-PCR, whereas those of KCNC4, KCNH1, 
and KCNJ13 were not identified (Fig. 5). The faint double bands of KCNJ13 in a human endolymphatic sac tissue 
sample (Fig. 5B) were revealed to be a product of non-specific amplification at a low target concentration after the 
sequencing of the purified PCR product.
Immunohistochemistry of K+ channels. Expression and localization of the K+ channels that were iden-
tified by RT-PCR were evaluated by immunohistochemistry. Immunohistochemical assessments indicated that 
all of the candidate channels except for KCNB1 were expressed in the ES epithelium (Fig. 6). These four channels 
were co-expressed with pendrin, which was thought to exist in the mitochondria-rich cells of ES epithelium10 
(Fig. 6a–d), but KCNJ14 was expressed in the ES epithelium without pendrin expression (Fig. 6b), which was 
suspected to occur in other cell types of ES epithelium, such as ribosome-rich cells.
Discussion
This report is the first to functionally identify electrogenic transport dependent on functional K+ channels in 
human ES epithelium. Thus far, there has been little interest in the K+ channel contribution in the electrogenic 
transport in ES epithelium; however, K+ ion transport–related electrogenic transport in human ES epithelium was 
positively identified in this study. This should contribute to the maintenance of a unique ionic milieu of the luminal 
fluid in human ES. The results of this study could be a basis for elucidating the role of human ES in regulating inner 
ear homeostasis and fluid regulation.
Evidence for the presence of K+ channels in the ES epithelium has been suggested by two animal studies with 
functional experiments16,17. The voltage-dependent outward K+ current was identified in the patch clamp exper-
iment using guinea pig ES epithelium, which was blocked by externally applied 4-AP (1 mM), Ba2+ (5 mM), and 
tetraethylammonium chloride (TEA, 20 mM)17. The K+ channel was thought to exist on the basolateral surface 
of ES epithelial cells, where it would function in conjunction with the Na+, K+ - ATPase to maintain the driving 
Figure 4. Representative figures for the changes in the trans-epithelial current from human ES after the 
application of blockers for Na+, K+-ATPase, and Na+, K+, 2Cl− cotransporter. (a) Inhibition of apical cation 
absorption/anion secretion current after the application of Na+, K+-ATPase blocker ouabain (1 mM).  
(b) Inhibition of cation secretion/anion absorption current after the application of Na+, K+, 2Cl− cotransporter 
blocker bumetanide (10 μ M).
www.nature.com/scientificreports/
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force for cation absorption through the apical membrane of the ES epithelial cells. Indirect evidence for the apical 
K+ conductance in the ES epithelium of guinea pig was proposed by measuring changes in the ES trans-epithelial 
potential while applying various K+ channel blockers to the ES lumen16. ES trans-epithelial potential was reduced 
immediately after the injection of control solution (100 mM NaCl, 15 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 60 mM 
mannitol; osmolarity = 280 mOsm/l) and recovered to the initial level within 30 min. However, the recovery of 
ES trans-epithelial potential was more delayed after the injection of TEA (20 mM), 4-AP (1 mM), and bumeta-
nide (100 μ M) compared to the control solution, which represented apical K+ conductance in the ES epithelium. 
Accession number Description (gene name) Max coverage (%) Max protein score
gi|6090615 dihydropyridine receptor alpha 2 subunit (CACNA2D1) 13.7 83
gi|38505268 voltage-dependent T-type calcium channel subunit alpha-1G isoform 14 (CACNA1G) 10.5 72
gi|7630181 alpha1A-voltage-dependent calcium channel (CACNA1A) 3.6 70
gi|292275 L-type voltage-dependent calcium channel (CACNA1) 6.1 66
gi|179764 calcium channel alpha-1D subunit (CACNA1D) 6.2 64
gi|20070163 voltage-dependent T-type calcium channel subunit alpha-1G isoform 1 (CACNA1G) 8.5 63
gi|5565888 T-type calcium channel alpha1I subunit (CACNA1I) 4.7 56
gi|14336738 voltage dependent t-type calcium channel alpha-1H subunit (CACNA1H) 5.4 52
gi|443761 voltage-operated calcium channel; alpha-1 subunit (CACNA1E) 7.2 54
gi|7159257 calcium channel alpha1E subunit; delta39 splice variant (CACNA1E) 10 56
gi|9711929 alpha1A-voltage-dependent calcium channel (CACNA1A) 10.3 55
gi|3183953 L-type calcium channel alpha-1 subunit (CACNA1F) 3.7 54
gi|55962840 calcium channel; voltage-dependent; N type; alpha 1B subunit (CACNA1B) 5.3 51
gi|4336152 low-voltage activated calcium channel alpha (CACNA1H) 4.9 51
gi|179762 calcium channel alpha-2b subunit (CACNA2D1) 7.1 51
gi|495868 voltage-dependent calcium channel alpha-1E-1 (CACNA1E) 5.6 50
gi|62088514 calcium channel; voltage-dependent; L type; alpha 1B subunit variant (CACNA1B) 11 46
gi|21314671 transient receptor potential cation channel subfamily M member 4 isoform 1 (TRPM4) 15.8 52
gi|54632969 long transient receptor potential channel 3 (TRPM3) 3.3 52
gi|76780233 TRPC4 protein (TRPC4) 5.4 54
gi|194733735 short transient receptor potential channel 3 isoform a (TRPC3) 7.9 47
gi|24119274 sodium leak channel non-selective protein (NALCN) 8.9 65
gi|189047 Na+ channel (SCN7A) 3.1 59
gi|25014054
RecName: Full = Sodium channel protein type 3 subunit alpha; AltName: 
Full = Sodium channel protein brain III subunit alpha; (AltName: 
Full = Sodium channel protein type III subunit alpha; AltName: 
Full = Voltage-gated sodium channel subtype III; AltName: Fu (SCN3A)
4.8 45
gi|6693697 voltage-gated sodium channel alpha subunit SCN12A (SCN12A) 6.9 45
gi|10334701 apamin-sensitive small-conductance Ca
2+-activated potassium channel 
(KCNN2) 7.4 57
gi|186798 voltage-gated potassium channel (KCNB1) 10.1 54
gi|338077 potassium channel protein (KCNC4) 6.4 53
gi|27437001 potassium voltage-gated channel subfamily H member 1 isoform 1 (KCNH1) 10 49
gi|21361181 sodium/potassium-transporting ATPase subunit alpha-1 isoform a (ATP1A1) 9.1 66
gi|497763 Na+; K+ -ATPase catalytic subunit (ATP1A3) 5.4 45
gi|14286105
RecName: Full = Plasma membrane calcium-transporting ATPase 
4; Short = PMCA4; AltName: Full = Matrix-remodelling-associated 
protein 1; AltName: Full = Plasma membrane calcium ATPase isoform 4; 
AltName: Full = Plasma membrane calcium pump isoform 4 (ATP2B4)
14.9 53
gi|118498343 calcium-transporting ATPase type 2C member 2 (ATP2C2) 13 48
gi|17865805 sodium/calcium exchanger 3 isoform B precursor (SLC8A3) 5.3 50
gi|15147254 sodium/calcium exchanger 3 isoform A precursor (SLC8A3) 9 46
gi|4505697 Pendrin (SLC26A4) 6 44
gi|68534512 Anoctamin 6 (ANO6) 8.7 52
Table 1.  Ion channels, transporters, and exchangers that were identified in the human ES by LC-MS/MS. 
Proteins searched through MASCOT (version 2.2.07) against the NCBInr database. The search parameters were: 1) 
Enzyme specificity - Trypsin; 2) Maximum missed cleavages - 2; 3) Carbamidomethyl (C); Oxidation (M) as variable 
modifications.
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Although these two studies suggested the location of K+ channels in ES epithelium, the location could not be 
exactly defined by the experiments. The former study inferred that a voltage-dependent K+ channel was located on 
the basolateral surface of the ES; however, the location of the K+ channels could not be exactly determined using 
only the whole cell patch clamp technique; the voltage-dependent K+ channel could be located on either the apical 
or the basolateral surface of the ES epithelium. The latter study applied the K+ channel blockers to the ES lumen 
(the apical side of the ES epithelium), which changed the recovery of ES trans-epithelial potential; therefore, the 
K+ channels could be suspected to be on the apical surface. However, this could not be used as direct evidence of 
apical K+ channel distribution, as K+ channel-mediated current was not directly measured on the apical surface 
of ES epithelium using a specific method such as an excised patch technique. In addition, the locally applied K+ 
channel blockers were able to influence the ion transport through multiple ion channels in the ES epithelium, 
which ultimately caused ES trans-epithelial potential change. In our study, we also could not be certain whether 
the location of the K+ channels identified by the experiments was apical or basolateral. Decreases in apical cation 
secretion current after the application of K+ channel blockers were detected and indicate two possibilities. One is 
the decreased K+ secretion through K+ channels in the apical side and the other is the changes in net trans-epithelial 
current vectors induced by the changes of various ion channel activities in ES epithelial cells mediated by K+ ion 
transport. For example, the active K+ channels may contribute to the trans-epithelial current change in some other 
way, such as by membrane voltage regulation of a Cl− current.
The current changes that were induced by K+ channel blockers, such as Ba2+ and 4-AP, were significantly larger 
than the amount of basal trans-epithelial current of human ES epithelium, indicating that multiple other cation 
absorption and anion secretion events should occur through the apical surface of human ES in addition to cation 
secretion/anion absorption dependent on functional K+ channels, which is also supported by the finding that 
the net basal current vectors varied, such as cation secretion/anion absorption (type 1), cation absorption/anion 
secretion (type 2), and neutral (type 3), regardless of the response to the K+ channel blockers. As reported previ-
ously in animal experiments, various ion channels absorbing Na+ exist on the apical surface of ES epithelium12. In 
addition, several pieces of evidence support the existence of chloride channels in the apical surface of the ES, and 
these channels would produce, when active and with frequently-observed electrochemical gradient favourable to 
Cl− secretion, the same directional current vector as do Na+-absorbing channels1,18. The activity of these chan-
nels can produce current vectors opposite to the cation secretion/anion absorption current vectors dependent on 
functional K+ channels, which finally caused three different types of net trans-epithelial current vectors according 
to the location of measurement, as shown in our experiment. Therefore, the amount of current change after the 
application of K+ channel blockers could be larger than the net basal current in human ES epithelium, especially 
with the application of non-specific broad-spectrum K+ channel blockers because they blocked multiple K+ chan-
nels, which caused a large amount of current change (the use of apamin, a specific blocker of KCNN2, induced a 
smaller amount of current change than the amount of basal current). The difference in the net basal current vector 
in each experiment was caused by the heterogeneous distribution of different epithelial cell types with unique ion 
channel distributions. The ion channel distribution according to each cell type should be functionally identified 
in future studies using molecular markers for each cell type.
We used RT-PCR and immunohistochemistry to identify the K+ channel candidates as revealed by LC-MS/MS 
and electrophysiological/pharmacological experiments. As a result, we finally identified the K+ channels of the 
ES epithelium among several candidate channels as KCNN2, KCNJ14, KCNK2, and KCNK6. The distribution of 
these channels in the ES epithelium was likely to be different according to cell type. Thus far, it was thought that 
most ion channels, including pendrin, were distributed in mitochondria-rich cells6–10. In this study, most of the K+ 
Figure 5. Transcript expression of the final candidate K+ channels (KCNB1, KCNC4, KCNH1, KCNN2, 
KCNJ13, KCNJ14, KCNK2, and KCNK6) identified by electrophysiological/pharmacological and LC-MS/MS 
experiments. (a) Transcript expression of the candidate K+ channels in the positive control (human kidney). 
(b) Transcript expression of the candidate K+ channels in the human ES. Transcripts of KCNB1, KCNN2, 
KCNJ14, KCNK2, and KCNK6 were detected by RT-PCR.
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channels, such as KCNN2, KCNK2, and KCNK6, were co-expressed in the cells in which pendrin was expressed, 
whereas KCNJ14 was mostly expressed in the cells in which pendrin was not expressed, meaning that KCNN2, 
KCNK2, and KCNK6 are likely to exist in mitochondria-rich cells and that KCNJ14 can exist in cells other than 
mitochondria-rich cells. Therefore, we can suggest that both cell types contribute to the homeostasis of ES luminal 
fluid by regulating the ion transport, in which K+ channels necessarily participate. Although we detected functional 
evidence for the existence of 4-AP sensitive K+ channels and transcript expression of 4-AP sensitive KCNB1 by 
the electrophysiological/pharmacological experiments and RT-PCR, we could not identify KCNB1 at the protein 
level by immunohistochemistry. It was not surprising in that RNA expression did not always correlate with protein 
expression and function. In addition, a proteomic analysis could yield false-positive results, as this method pro-
vides screening data for the protein compositions of certain tissues by analysing the amino acid sequences using 
spectrometry and statistical analyses. We also could not identify inwardly rectifying K+ channels in the LC-MS/MS 
that were detected in the electrophysiological/pharmacological experiment, representing the possible limitation 
of LC-MS/MS as a screening test. Instead, there should be 4-AP-sensitive K+ channels other than KCNB1 in the 
human ES epithelium because 4-AP is a non-selective, wide-spectrum, voltage-dependent K+ channel blocker. 
Figure 6. Immunofluorescent staining of K+ channels (KCNB1, KCNN2, KCNJ14, KCNK2, and KCNK6) 
identified by RT-PCR. (a) KCNN2. (b) KCNJ14. (c) KCNK2. (d) KCNK6. The K+ channels except for 
KCNB1 were detected by immunofluorescent staining. Pendrin antibody was used for the validation of the ES 
epithelium because pendrin exists in mitochondria-rich cells of ES epithelial cells.
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These channels should be identified in the near future using more sensitive screening tests followed by functional 
and molecular studies using more specific pharmacologic agents and specific markers.
One of the main roles of K+ channels in the inner ear is the maintenance of high K+ ions in the endolymph. 
In addition, K+ channels in the cochlea are involved in creating high positive potential (endocochlear potential 
≈ 80–100 mV) in the endolymphatic space of the cochlear compartment to facilitate the K+ absorption through 
hair cells3. The K+ ion concentration of the endolymph is maintained mainly by K+ secretion from inner ear epi-
thelial cells. The two sites for K+ secretion are the stria vascularis in the cochlea compartment and the dark cells 
in the vestibular compartment19. The mechanism for K+ secretion in both structures is virtually identical. The 
stria vascularis consists of three cell layers (basal cells, intermediate cells, and marginal cells) and low K+ concen-
tration fluid fills the space between intermediate cells and marginal cells (intrastrial space), although dark cells do 
not have such layers19. The marginal cells and basal cells are each linked among themselves by tight junctions. In 
the stria vascularis, K+ ions are taken up from the abluminal fluid (also known as the perilymph) through Na+, 
K+-ATPase and NKCC in basal cells and moved to intermediate cells via gap junctions19. Intermediate cells release 
the K+ ions into the intrastrial space through KCNJ10, and the released K+ ions are taken up into marginal cells 
through basolateral Na+, K+-ATPase and NKCC and then secreted into the endolymph through KCNQ1/KCNE1 
K+ channels19. The equilibrium K+ potential generated by KCNJ10 in intermediated cells in conjunction with a low 
extracellular K+ concentration in the intrastrial space and a high cysosolic K+ concentration in intermediate cells 
creates the endocochlear potential19. In dark cells, K+ ions are taken up through basolateral Na+, K+-ATPase and 
NKCC, and then secreted into the endolymph through KCNQ1/KCNE1 K+ channels19; however, there is no high 
positive potential in the vestibular compartment, because of the absence of intermediate cells and the absence of 
completely separated low K+ concentration space as found in stria vascularis.
Although the K+ secretion and their roles were well-known in the cochlear and vestibular compartment, 
the distribution and the roles of K+ channels in ES is still unclear. The K+ channels in human ES varied in our 
study, and it seems that those channels essentially contribute to the electrogenic transport in ES epithelium. Na+, 
K+-ATPase and NKCC were also likely to be involved in the K+ ion transport by placing K+ ions into cytosol. 
Other ion channels, transporters, and exchangers responsible the movement of abundant ions, such as Na+, Cl−, 
and Ca2+ could be involved in the regulation of the electrogenic transport of ES epithelium, which should be 
closely related to K+ channel activity as various ion movements have been observed in ES epithelium in animal 
experiments12. To identify the exact mechanism involved in producing net electrogenic transport in human ES 
epithelium related to the K+ ion transport, further studies for various cation and anion movements through the 
ES epithelium should be conducted.
Conclusion
Trans-epithelial current dependent on functional K+ channels was identified in the human ES epithelium by elec-
trophysiological, pharmacological, and molecular biological methods in this study. K+ channels, including KCNN2, 
KCNJ14, KCNK2, and KCNK6, were involved in the electrogenic transport of human ES epithelium coupled with 
the activity of NKCC/Na+, K+ - ATPase. This K+ transport is thought to play an important role in the maintenance 
of inner ear homeostasis by participating in the regulation of electrogenic transport.
Materials and Methods
Harvesting ES. Human ES was harvested during acoustic tumour surgery via a translabyrinthine approach 
in 16 patients (M:F = 5:11, mean age: 50.9 ± 3.0 years). The bony surface covering the posterior fossa dura and ES 
was carefully thinned with drilling and then peeled off to expose the whole ES. After exposing the ES, ~200 μ l of 
physiological saline was injected to prevent damage to the luminal surface during dissection. The ES was carefully 
dissected after the incision of the ES border, and the luminal surface was exposed. The harvested ES was immersed 
in perilymph-like solution (specified in transepithelial current measurement) and was used immediately for the 
experiment.
Trans-epithelial current measurement. The scanning vibrating electrode technique was used to measure 
trans-epithelial current from the ES epithelium as previously described20. To measure the trans-epithelial current 
from the tissue, the harvested ES was divided into small pieces (~3 × 3 mm), and the prepared tissue was smoothly 
folded apical side-out (Fig. 2a). The tissue was mounted in a perfusion chamber of an inverted microscope (IX51, 
Olympus, Tokyo, Japan) and continuously perfused at 37 °C with an exchange rate of 1.2 times/sec. The current 
density was monitored by vibrating a platinum-iridium wire microelectrode insulated with parlene-C (Micro 
Electrodes, Gaithersburg, MD, USA) and coated with Pt black on the exposed tip. The electrode tip of the probe 
was vibrated at two frequencies between 400 and 700 Hz along horizontal (x) and vertical (z) axes by piezo-electric 
bimorph elements (Applicable Electronics, Forestdale, MA, USA) and was positioned 5 ± 2 μ m from the apical 
surface of the epithelium (Fig. 2a). The x-axis was perpendicular to the face of the epithelium. A platinum-black 
electrode served as reference in the bath chamber. The signals from the oscillators driving the probe, which were 
connected to a dual-channel phase-sensitive detector (Applicable Electronics), were digitized (16 bit) at a rate of 
0.5 Hz. The electrode was positioned so that the current density showed a maximum x value and a minimum z 
value. The data that were derived from the x direction current density were plotted with Origin software, version 
8.0. (OriginLab Software, Northampton, MA, USA).
For electrophysiological experiments, a perilymph-like physiological saline solution [150 mM NaCl, 3.6 mM 
KCl, 1 mM MgCl2, 0.7 mM CaCl2, 5 mM glucose, and 10 mM HEPES (pH 7.4)] was used for perfusion. The phar-
macologic agents that were used in this study were purchased from Sigma (St. Louis, MO, USA). All agents 
except ouabain and bumetanide were dissolved in the perilymph-like solution before application. Ouabain and 
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bumetanide were dissolved in DMSO (Sigma) and then diluted to < 0.1% DMSO in perilymph-like solution before 
application. DMSO at this concentration had no effect on current density21.
Identification of the ES protein by LC-MS/MS. For the screening of the existence of various ion channels, 
transporters, and exchangers in human ES, LC-MS/MS was performed. Two harvested ES tissues were suspended 
in 500 μ l of sample buffer (7 M urea, 2 M thiourea, 4% CHAPS, 0.5% ampholyte, 100 mM DTT, 40 mM Tris, 0.002% 
bromophenol blue) and were sonicated for 10 seconds 10 times with 10-second intervals. Then, 10 μ l of DNase 
(10,000 U/ml) was added and incubated at 4 °C for 30 min. After incubation, the supernatant was centrifuged at 
105,000 g for 45 min. Then, 50% trichloroacetic acid was added to a final concentration of 5–8%, and the sample was 
incubated on ice for 2 hours. The sample was centrifuged at 14,000 g for 15 min, and the supernatant was discarded. 
Cold acetone (200 μ l) was added, and the sample was incubated on ice for 15 min. The sample was centrifuged at 
14,000 g for 20 min, and the supernatant acetone was discarded. The pellet was dried in air and dissolved in sample 
buffer. The protein concentration was quantified by the Bradford protein assay.
Thirty micrograms of ES protein was used for one-dimensional gel electrophoresis (1-DE) . The samples were 
lyophilized and dissolved in 15 μ l of distilled water. Samples were subjected to sodium dodecyl sulphate gel elec-
trophoresis on an 8–16% Tris/Glycine gel and stained with Coomassie Brilliant Blue. The entire 1-DE gel lane was 
cut into 8 pieces according to molecular weight for digestion. After reduction with dithiothreitol and alkylation 
with iodoacetamide, each piece of gel was treated with trypsin for in situ digestion and then washed with 10 mM 
ammonium bicarbonate and 50% acetonitrile and swollen in digestion buffer containing 50 mM ammonium 
bicarbonate, 5 mM CaCl2, and 1 μ g of trypsin. Next, the gel was incubated at 37 °C for 12 hours. Peptides were 
recovered over the course of 2 extraction cycles with 50 mM ammonium bicarbonate and 100% acetonitrile. The 
resulting peptide extracts were pooled, lyophilized, and stored at -20 °C.
Nano LC-MS/MS analysis was performed on an Agilent 1100 Series nano-LC and linear trap quadrupole 
(LTQ)-mass spectrometer (Thermo Electron, San Jose, CA). The capillary column that was used for LC-MS/MS 
analysis (150 mm × 0.075 mm) was obtained from Proxeon (Odense M, Denmark), and slurry-packed in-house 
with 5 μ g, 100 Å pore size Magic C18 stationary phase (Michrom Bioresources, Auburn, CA). Mobile phase A for 
LC separation was 0.1% formic acid in deionized water, and mobile phase B was 0.1% formic acid in acetonitrile. 
Chromatography was performed using a linear gradient from 5% B to 35% B over 100 min, from 40% B to 60% 
B over 10 min, and from 60% B to 80% B over 20 min. The flow rate was maintained at 300 nl/min after splitting. 
Mass spectra were acquired using data-dependent acquisition with a full mass scan (400–1800 m/z) followed by 
MS/MS scans. Each acquired MS/MS scan represented the average of one microscan on the LTQ. The temperature 
of the ion transfer tube was controlled at 200 °C, and the spray was 1.5–2.0 kV. The normalized collision energy 
was set at 35% for MS/MS.
The MASCOT and SEQUEST (Bioworks software version 3.2, Thermo Electron, Waltham, MA, USA) search 
engines were used to search the UniProt human protein databases (release 14.8; 82728 sequences) for tandem mass 
spectra. Mass tolerances of 1.2 and 0.6 Da were used for precursor and fragment ions, respectively. The search 
included variable modifications of oxidation on methionine and carbamidomethyl of cysteine. PeptideProphet 
and ProteinProphet were used to estimate the false discovery rate (FDR) for any minimum probability that was 
used as a cut-off for the MASCOT and SEQUEST search results. Proteins for ion channels, transporters, and 
exchangers in the data were checked.
RT-PCR. After the homogenization of the harvested human ES tissue, the total RNA was extracted using 
TRIzol® (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s protocol. The quantity and quality of iso-
lated RNA were determined with a NanoDrop ND-100 spectrophotometer (NanoDrop Technologies, Wilmington, 
DE, USA) and by analysing the 18S and 28S rRNA bands after electrophoresis. cDNA was synthesized from 3 μ g 
of total RNA with random hexamer primers (Perkin Elmer Life Sciences, Boston, MA, USA and Roche Applied 
Science, Mannheim, Germany), AMV reverse transcriptase (Perkin Elmer Life Sciences), and RNase inhibitor 
(Perkin Elmer Life Sciences). The reverse transcription step was performed for 10 min at room temperature, 30 min 
at 50 °C, and 15 min at 95 °C.
To verify the genomic expression of ion channels, transporters, and exchangers that were identified by LC-MS/
MS and electrophysiological/pharmacological studies, RT-PCR was performed. The transcript of each ion chan-
nel was amplified using gene-specific primers (Table 2). The PCR conditions included 30 cycles of denaturation 
at 94 °C for 30 seconds, annealing at 54 °C for 30 seconds, and polymerization at 72 °C for 30 seconds. The PCR 
products were run on a 1.5% agarose gel and visualized with ethidium bromide under a transilluminator. Total 
RNA extracted from human kidney (Clontech, Takara Korea Biomedical Inc., Seoul, Korea) was used as a positive 
control for K+ channels. All PCR products were purified by a PCR purification kit (Qiagen, Valencia, CA, USA), 
and the resulting purified PCR products were sequenced to verify the identity of the RT-PCR product.
Immunohistochemistry. To verify the protein expression of K+ channels as identified by LC-MS/MS, 
RT-PCR and electrophysiological/pharmacological studies, immunohistochemistry was performed. We used 
pendrin as a marker for the mitochondria-rich cells of the ES. Human ES tissues were fixed with 4% paraformalde-
hyde for 24 hours and then dehydrated and embedded in paraffin. Paraffin blocks were sectioned into 5-μ m-thick 
slices and attached on slide glasses. The samples were deparaffinized twice in xylene for 5 min and hydrated with 
100% and 95% ethanol twice for 3 and 2 min, respectively. After washing the sample with distilled water, antigen 
retrieval was performed in pH 9.0 Tris-EDTA buffer for 20 min using a microwave. The samples were blocked 
with blocking solution (Lab Vision Ultra V Block, Thermo Scientific, Waltham, MA, USA) for 1 hour and then 
washed for 5 min 3 times in PBS. The samples were incubated overnight at 4 °C with the first primary antibodies 
[KCNB1 (1:100, ab111122, Abcam, Cambridge, MA, USA), KCNN2 (1:200, LS-A9578, LSBIO, Seattle, WA, USA), 
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KCNK2 (1:200, ab83932, Abcam), KCNK6 (1:200, hpa040184, Atlas Antibodies, Stockholm, Sweden), and KCNJ14 
(1:50, sc-23633, Santa Cruz, Dallas, TX, USA) for each sample]. After incubation, the samples were washed and 
incubated with secondary antibodies according to the use of first primary antibodies [1:200 goat anti-rabbit Alexa 
Fluor 568 for KCNB1, KCNN2, KCNK2, KCNK6 (ab175471, Abcam) or 1:200 donkey anti-goat Alexa Fluor 488 
for KCNJ14 ab175704, Abcam)] for 1 hour at room temperature. The samples were washed and blocked with the 
blocking solution for 1 hour. Then, the samples were incubated overnight at 4 °C with the second primary antibody 
(pendrin, 1:50, sc-23779, Santa Cruz). After incubation, the samples were washed and incubated with secondary 
antibodies for pendrin [1:200 donkey anti-goat Alexa 488 Fluor (ab150129, Abcam) for the samples previously 
treated with Alexa 568 Fluor and 1:200 donkey anti-goat Alexa 568 (ab175704) for the samples previously treated 
with Alexa 488 Fluor] for 1 hour at room temperature. The samples were washed, and the nuclei of the tissues were 
stained with 4’,6-diamidino-2-phenylindole (DAPI). The samples on the slide glasses were mounted with cover 
glass, and the expression levels of the channels were observed with confocal laser scanning microscopy (LSM780, 
Carl Zeiss, Jena, Germany)
Data analysis. The results are presented as the means ± SE from n observations. The amount of the 
trans-epithelial current change was calculated as follows. The basal current amount was calculated by subtracting 
the current at the reference point (400 μ M from the epithelium) from the trans-epithelial current obtained during 
the first 30 seconds after locating the probe on the apical side of the epithelium. The current changes that were 
induced by the application of pharmacologic agents were calculated by subtracting the basal current from the 
trans-epithelial current obtained during the last 30 seconds after the application of the pharmacologic agent. The 
significance of the changes of the current density after the application of pharmacologic agents was calculated using 
the student t-test or Mann-Whitney U test. A value of p < 0.05 was considered significant.
Ethics statement. This study was approved by the institutional review board of Severance Hospital, Yonsei 
University College of Medicine, and written informed consent was obtained from each of the participants. The 
experimental methods were carried out in accordance with the approved guidelines.
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